Coherus Oncology (CHRS) Common Equity (2013 - 2026)
Coherus Oncology (CHRS) posted Common Equity of $60.84 million for Q2 2026, down 49.2% from $119.83 million a year earlier and down 22.6% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Common Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology's Common Equity came in at $61.01 million.
- Annual Common Equity shows a five-year compound annual growth rate of -26.3% (FY2020 to FY2025).
- In prior years, Coherus Oncology's Common Equity was -$131.99 million in FY2024, -$193.43 million in FY2023, -$137.42 million in FY2022 and $97.73 million in FY2021 (-65.2%).
- The Q2 2026 figure stands as the lowest quarterly Common Equity since Q1 2025.
- According to Business Quant data, Common Equity for the three prior quarters was $78.62 million (Q1 2026), $61.01 million (Q4 2025) and $87.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 60.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.84 Mn |
| Mar 31, 2026 | 78.62 Mn |
| Dec 31, 2025 | 61.01 Mn |
| Sep 30, 2025 | 87.77 Mn |
| Jun 30, 2025 | 119.83 Mn |
| Mar 31, 2025 | -183.47 Mn |
| Dec 31, 2024 | -131.99 Mn |
| Sep 30, 2024 | -87.97 Mn |
| Jun 30, 2024 | -84.11 Mn |
| Mar 31, 2024 | -81.84 Mn |
| Dec 31, 2023 | -193.43 Mn |
| Sep 30, 2023 | -133.60 Mn |
| Jun 30, 2023 | -174.76 Mn |
| Mar 31, 2023 | -196.51 Mn |
| Dec 31, 2022 | -137.42 Mn |
| Sep 30, 2022 | -97.13 Mn |
| Jun 30, 2022 | -22.63 Mn |
| Mar 31, 2022 | 12.56 Mn |
| Dec 31, 2021 | 97.73 Mn |
| Sep 30, 2021 | 130.76 Mn |
API Access
Coherus Oncology Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();